[Reproductive Health-Oriented Development in Assisted Reproductive Technologies].

以生殖健康为导向的辅助生殖技术发展.

Journal

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
ISSN: 1672-173X
Titre abrégé: Sichuan Da Xue Xue Bao Yi Xue Ban
Pays: China
ID NLM: 101162609

Informations de publication

Date de publication:
20 May 2024
Historique:
received: 19 01 2024
medline: 1 7 2024
pubmed: 1 7 2024
entrez: 1 7 2024
Statut: ppublish

Résumé

Assisted reproductive technologies (ARTs) are core components of the field of reproductive medicine, encompassing multiple pivotal stages of early development from gamete maturation and fertilization to embryo development. Against the backdrop of a deteriorating trend of global decline in fertility rates, patients with infertility problems increasingly turn to ARTs to realize their dreams of parenthood. However, concomitant with this trend is a growing apprehension regarding the potential adverse effects of ARTs. Herein, we endeavor to discuss several common ARTs procedures utilized in clinical settings and the relevant cutting-edge advancements. The ARTs discussed in the article include

Identifiants

pubmed: 38948299
doi: 10.12182/20240560401
pii: scdxxbyxb-55-3-501
pmc: PMC11211779
doi:

Types de publication

Journal Article Review English Abstract

Langues

chi

Sous-ensembles de citation

IM

Pagination

501-506

Informations de copyright

© 2024《四川大学学报(医学版)》编辑部 版权所有Copyright ©2024 Editorial Office of Journal of Sichuan University (Medical Sciences).

Déclaration de conflit d'intérêts

利益冲突 所有作者均声明不存在利益冲突

Auteurs

Peiran Hu (P)

( 200030) Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai 200030, China.

Jiexue Pan (J)

( 200030) Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai 200030, China.

Xinmei Liu (X)

( 200030) Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai 200030, China.

Hefeng Huang (H)

( 200030) Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai 200030, China.
( 200030) Shanghai Key Laboratory of Reproduction and Development, Shanghai 200030, China.
2019RU056 ( 200030) Research Units of Diseases of Embryonic Origin (No. 2019RU056), Chinese Academy of Medical Sciences, Shanghai 200030, China.
( 310030) Key Laboratory of Reproductive Genetics of the Ministry of Education, Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310030, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH